318 related articles for article (PubMed ID: 22671039)
1. Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia.
Loewenthal R; Rosenberg N; Kalt R; Dardik R; Landau M; Yahalom V; Avishai O; Frenkel O; Gazit E; Steinberg DM; Lipitz S; Salomon O
Transfusion; 2013 Feb; 53(2):344-52. PubMed ID: 22671039
[TBL] [Abstract][Full Text] [Related]
2. HLA-DRB3*01:01 is a predictor of immunization against human platelet antigen-1a but not of the severity of fetal and neonatal alloimmune thrombocytopenia.
Wienzek-Lischka S; König IR; Papenkort EM; Hackstein H; Santoso S; Sachs UJ; Bein G
Transfusion; 2017 Mar; 57(3):533-540. PubMed ID: 28019029
[TBL] [Abstract][Full Text] [Related]
3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of HPA-1a alloimmunization and the potential risk of FNAIT depend on both the DRB3*01:01 allele and associated DR-DQ haplotypes.
Ahlen MT; Heide G; Husebekk A; Skogen B; Kjeldsen-Kragh J; Stuge TB
Scand J Immunol; 2020 Jul; 92(1):e12890. PubMed ID: 32299122
[TBL] [Abstract][Full Text] [Related]
5. Maternal HLA genotyping is not useful for predicting severity of fetal and neonatal alloimmune thrombocytopenia.
Sainio S; Javela K; Tuimala J; Haimila K
Br J Haematol; 2017 Jan; 176(1):111-117. PubMed ID: 27748520
[TBL] [Abstract][Full Text] [Related]
6. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
7. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
[TBL] [Abstract][Full Text] [Related]
8. Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.
Kjeldsen-Kragh J; Ahlen MT
Transfus Apher Sci; 2020 Feb; 59(1):102707. PubMed ID: 31919011
[TBL] [Abstract][Full Text] [Related]
9. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
10. Fetal and neonatal alloimmune thrombocytopenia.
van den Akker ES; Oepkes D
Best Pract Res Clin Obstet Gynaecol; 2008 Feb; 22(1):3-14. PubMed ID: 17936686
[TBL] [Abstract][Full Text] [Related]
11. Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT): Scientific Impact Paper No. 61.
Regan F; Lees CC; Jones B; Nicolaides KH; Wimalasundera RC; Mijovic A;
BJOG; 2019 Sep; 126(10):e173-e185. PubMed ID: 30968555
[TBL] [Abstract][Full Text] [Related]
12. Immunization against a low-frequency human platelet alloantigen in fetal alloimmune thrombocytopenia is not a single event: characterization by the combined use of reference DNA and novel allele-specific cell lines expressing recombinant antigens.
Kroll H; Yates J; Santoso S
Transfusion; 2005 Mar; 45(3):353-8. PubMed ID: 15752152
[TBL] [Abstract][Full Text] [Related]
13. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
Sachs UJ; Wienzek-Lischka S; Duong Y; Qiu D; Hinrichs W; Cooper N; Santoso S; Bayat B; Bein G
Br J Haematol; 2020 May; 189(4):751-759. PubMed ID: 31997312
[TBL] [Abstract][Full Text] [Related]
14. HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women.
Kjeldsen-Kragh J; Titze TL; Lie BA; Vaage JT; Kjær M
Blood Adv; 2019 Apr; 3(7):945-951. PubMed ID: 30923048
[TBL] [Abstract][Full Text] [Related]
15. The αIIb p.Leu841Met (Cab3(a+) ) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia.
Jallu V; Bertrand G; Bianchi F; Chenet C; Poulain P; Kaplan C
Transfusion; 2013 Mar; 53(3):554-63. PubMed ID: 22738334
[TBL] [Abstract][Full Text] [Related]
16. Foetal/neonatal alloimmune thrombocytopenia in Egypt; human platelet antigen genotype frequencies and antibody detection and follow-up in pregnancies.
Husebekk A; El Ekiaby M; Gorgy G; Killie MK; Uhlin-Hansen C; Salma W; Navarrete C; El Afandi M; Skogen B; Ahlen MT
Transfus Apher Sci; 2012 Dec; 47(3):277-82. PubMed ID: 22640833
[TBL] [Abstract][Full Text] [Related]
17. The new platelet alloantigen Cab a: a single point mutation Gln 716 His on the alpha 2 integrin.
Bertrand G; Jallu V; Saillant D; Kervran D; Martageix C; Kaplan C
Transfusion; 2009 Oct; 49(10):2076-83. PubMed ID: 19500323
[TBL] [Abstract][Full Text] [Related]
18. [PREVFNAIT prevention of foetal/neonatal alloimmune thrombocytopenia (FNAIT) in Polish foetuses and newborns--the PREVFNAIT program].
Uhrynowska ME; Dębska M; Guz K; Orzińska A; Wróbel A; Maślanka K; Dębski R; Brojer E
Ginekol Pol; 2015 Jan; 86(1):62-6. PubMed ID: 25775877
[TBL] [Abstract][Full Text] [Related]
19. Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.
Bonstein L; Haddad N
Thromb Res; 2017 Mar; 151 Suppl 1():S100-S102. PubMed ID: 28262226
[TBL] [Abstract][Full Text] [Related]
20. Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review.
Kamphuis MM; Paridaans N; Porcelijn L; De Haas M; Van Der Schoot CE; Brand A; Bonsel GJ; Oepkes D
BJOG; 2010 Oct; 117(11):1335-43. PubMed ID: 20618318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]